$619.21
0.74% yesterday
NYSE, Apr 03, 10:00 pm CET
ISIN
US16359R1032
Symbol
CHE

Chemed Corporation Target price 2025 - Analyst rating & recommendation

Chemed Corporation Classifications & Recommendation:

Buy
75%
Hold
25%

Chemed Corporation Price Target

Target Price $675.00
Price $619.21
Potential
Number of Estimates 3
3 Analysts have issued a price target Chemed Corporation 2026 . The average Chemed Corporation target price is $675.00. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 4 analysts: 3 Analysts recommend Chemed Corporation to buy, 1 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Chemed Corporation stock has an average upside potential 2026 of . Most analysts recommend the Chemed Corporation stock at Purchase.

Sales and Margin forecast 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Billion $ 2.43 2.62
7.37% 7.96%
EBITDA Margin 17.93% 20.22%
0.59% 12.75%
Net Margin 11.91% 12.51%
3.32% 5.03%

3 Analysts have issued a sales forecast Chemed Corporation 2025 . The average Chemed Corporation sales estimate is

$2.6b
Unlock
. This is
7.96% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$2.6b 8.09%
Unlock
, the lowest is
$2.6b 7.78%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $2.4b 7.37%
2025
$2.6b 7.96%
Unlock
2026
$2.8b 6.67%
Unlock
2027
$3.0b 6.09%
Unlock

3 Analysts have issued an Chemed Corporation EBITDA forecast 2025. The average Chemed Corporation EBITDA estimate is

$531m
Unlock
. This is
23.52% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$532m 23.87%
Unlock
, the lowest is
$530m 23.33%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 $436m 8.00%
2025
$531m 21.74%
Unlock
2026
$563m 6.15%
Unlock
2027
$591m 4.93%
Unlock

EBITDA Margin

2024 17.93% 0.59%
2025
20.22% 12.75%
Unlock
2026
20.12% 0.49%
Unlock
2027
19.90% 1.09%
Unlock

2 Chemed Corporation Analysts have issued a net profit forecast 2025. The average Chemed Corporation net profit estimate is

$328m
Unlock
. This is
13.26% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$339m 16.78%
Unlock
, the lowest is
$318m 9.75%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $290m 10.93%
2025
$328m 13.37%
Unlock
2026
$361m 10.07%
Unlock

Net Margin

2024 11.91% 3.32%
2025
12.51% 5.03%
Unlock
2026
12.91% 3.20%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share $ 19.89 22.55
10.93% 13.37%
P/E 27.46
EV/Sales 3.44

2 Analysts have issued a Chemed Corporation forecast for earnings per share. The average Chemed Corporation EPS is

$22.55
Unlock
. This is
13.26% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
$23.25 16.78%
Unlock
, the lowest is
$21.85 9.74%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $19.89 10.93%
2025
$22.55 13.37%
Unlock
2026
$24.82 10.07%
Unlock

P/E ratio

Current 31.11 13.17%
2025
27.46 11.73%
Unlock
2026
24.95 9.14%
Unlock

Based on analysts' sales estimates for 2025, the Chemed Corporation stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 3.71 12.50%
2025
3.44 7.32%
Unlock
2026
3.22 6.25%
Unlock
2027
3.04 5.74%
Unlock

P/S ratio

Current 3.73 13.02%
2025
3.45 7.38%
Unlock
2026
3.24 6.25%
Unlock
2027
3.05 5.74%
Unlock

Current Chemed Corporation Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
RBC Capital
Locked
Locked
Locked Mar 14 2025
RBC Capital
Locked
Locked
Locked Nov 05 2024
Analyst Rating Date
Locked
RBC Capital:
Locked
Locked
Mar 14 2025
Locked
RBC Capital:
Locked
Locked
Nov 05 2024

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today